169945-28-2

Upstream product

• 876-08-4 p-(chloromethyl)benzoyl chloride 
• 90-04-0 2-methoxy-phenylamine 

Downstream Products

• 169945-57-7 4-methoxymethyl-N-(2-methoxyphenyl)benzamide 
• 169945-70-4 N-(2-Methoxyphenyl)-4-(methylamino)methylbenzamide 
• 169946-27-4 4-(N-tert-Butoxycarbonyl-N-methylamino)methyl-N-{2-[4-(4-fluorobenzoyl)piperidino]ethyl}-N-(2-methoxyphenyl)benzamide 
• 204643-87-8 4-(N-tert-butoxycarbonyl-N-methylamino)methyl-N-(2-methoxyphenyl)benzamide 

Relevant academic research and scientific papers

Synthesis and in vitro antiproliferative evaluation of novel hybrids from 1,3,4-Thiadiazole and benzisoselenazolone

Novel hybrids from 1,3,4-thiadiazole and benzisoselenazolone were designed, synthesized and evaluated for their in vitro antiproliferative activities by CCK-8 assay against three types of human cancer cell lines, SMMC-7721, MCF-7 and A549 cells. The preli

Substituted cyclic amine compound, production process thereof and pharmaceutical composition for circulatory organ use containing the same

A substituted cyclic amine compound represented by the following general formula (1) STR1 wherein each of R1 to R5 represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group or the like, A represents a carbonyl group or a sulfonyl group, B represents a methine moiety or a nitrogen atom, D represents a methine moiety, a nitrogen atom or =N(→O)-- and n is an integer of 2 to 3; and synthetic methods thereof. The inventive compound is useful in preventing and treating circulatory organ-related diseases such as hypertension, ischemic heart disease, cerebrovascular disease, peripheral circulatory disease and the like.